Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Shares Outstanding (Weighted Average) (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Shares Outstanding (Weighted Average) for 14 consecutive years, with $18.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 4.27% to $18.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $18.3 million, a 4.27% decrease, with the full-year FY2024 number at $19.1 million, down 0.76% from a year prior.
  • Shares Outstanding (Weighted Average) was $18.3 million for Q3 2025 at Usana Health Sciences, down from $18.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $21.2 million in Q1 2021 to a low of $18.3 million in Q3 2025.
  • A 5-year average of $19.3 million and a median of $19.2 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): dropped 4.77% in 2022, then grew 0.2% in 2023.
  • Usana Health Sciences' Shares Outstanding (Weighted Average) stood at $20.0 million in 2021, then dropped by 3.54% to $19.3 million in 2022, then fell by 0.02% to $19.2 million in 2023, then fell by 0.76% to $19.1 million in 2024, then decreased by 4.24% to $18.3 million in 2025.
  • Per Business Quant, the three most recent readings for USNA's Shares Outstanding (Weighted Average) are $18.3 million (Q3 2025), $18.8 million (Q2 2025), and $19.0 million (Q1 2025).